Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120


Randomised, double-blind, multicentre, mixed-methods, dose-escalation feasibility trial of mirtazapine for better treatment of severe breathlessness in advanced lung disease (BETTER-B feasibility).

Higginson IJ, Wilcock A, Johnson MJ, Bajwah S, Lovell N, Yi D, Hart SP, Crosby V, Poad H, Currow D, Best E, Brown S; BETTER-B Feasibility Trial Group.

Thorax. 2020 Feb;75(2):176-179. doi: 10.1136/thoraxjnl-2019-213879. Epub 2020 Jan 8.


Characterisation of a New Human Alveolar Macrophage-Like Cell Line (Daisy).

Sadofsky LR, Hayman YA, Vance J, Cervantes JL, Fraser SD, Wilkinson HN, Williamson JD, Hart SP, Morice AH.

Lung. 2019 Dec;197(6):687-698. doi: 10.1007/s00408-019-00288-3. Epub 2019 Nov 16.


Monocytes and macrophages in chronic sarcoidosis pathology.

Fraser SD, Hart SP.

Eur Respir J. 2019 Nov 14;54(5). pii: 1901626. doi: 10.1183/13993003.01626-2019. Print 2019 Nov. No abstract available.


Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.

Allen RJ, Guillen-Guio B, Oldham JM, Ma SF, Dressen A, Paynton ML, Kraven LM, Obeidat M, Li X, Ng M, Braybrooke R, Molina-Molina M, Hobbs BD, Putman RK, Sakornsakolpat P, Booth HL, Fahy WA, Hart SP, Hill MR, Hirani N, Hubbard RB, McAnulty RJ, Millar AB, Navaratnam V, Oballa E, Parfrey H, Saini G, Whyte MKB, Zhang Y, Kaminski N, Adegunsoye A, Strek ME, Neighbors M, Sheng XR, Gudmundsson G, Gudnason V, Hatabu H, Lederer DJ, Manichaikul A, Newell JD Jr, O'Connor GT, Ortega VE, Xu H, Fingerlin TE, Bossé Y, Hao K, Joubert P, Nickle DC, Sin DD, Timens W, Furniss D, Morris AP, Zondervan KT, Hall IP, Sayers I, Tobin MD, Maher TM, Cho MH, Hunninghake GM, Schwartz DA, Yaspan BL, Molyneaux PL, Flores C, Noth I, Jenkins RG, Wain LV.

Am J Respir Crit Care Med. 2020 Mar 1;201(5):564-574. doi: 10.1164/rccm.201905-1017OC.


A feasibility, randomised controlled trial of a complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): study protocol.

Wright C, Hart SP, Allgar V, English A, Swan F, Dyson J, Richardson G, Twiddy M, Cohen J, Hussain J, Johnson M, Hargreaves I, Crooks MG.

ERJ Open Res. 2019 Oct 21;5(4). pii: 00186-2019. doi: 10.1183/23120541.00186-2019. eCollection 2019 Oct.


Signatures of selection for resistance to Haemonchus contortus in sheep and goats.

Estrada-Reyes ZM, Tsukahara Y, Amadeu RR, Goetsch AL, Gipson TA, Sahlu T, Puchala R, Wang Z, Hart SP, Mateescu RG.

BMC Genomics. 2019 Oct 15;20(1):735. doi: 10.1186/s12864-019-6150-y.


Across and within breed differences in the relationship between packed cell volume and fecal egg count in growing meat goat and hair sheep males naturally and artificially infected with gastrointestinal nematodes.

Tsukahara Y, Gipson TA, Hart SP, Dawson LJ, Wang Z, Puchala R, Sahlu T, Goetsch AL.

Vet Parasitol Reg Stud Reports. 2019 Aug;17:100311. doi: 10.1016/j.vprsr.2019.100311. Epub 2019 May 31.


Authors' Response.

Swan F, English A, Allgar V, Hart SP, Johnson MJ.

J Pain Symptom Manage. 2019 Aug;58(2):e2-e3. doi: 10.1016/j.jpainsymman.2019.03.009. Epub 2019 Mar 21. No abstract available.


The Hand-Held Fan and the Calming Hand for People With Chronic Breathlessness: A Feasibility Trial.

Swan F, English A, Allgar V, Hart SP, Johnson MJ.

J Pain Symptom Manage. 2019 Jun;57(6):1051-1061.e1. doi: 10.1016/j.jpainsymman.2019.02.017. Epub 2019 Feb 23.


Do soil biota influence the outcome of novel interactions between plant competitors?

Cardinaux A, Hart SP, Alexander JM.

J Ecol. 2018 Aug 13;106(5):1853-1863. doi: 10.1111/1365-2745.13029.


Effects of rapid evolution on species coexistence.

Hart SP, Turcotte MM, Levine JM.

Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):2112-2117. doi: 10.1073/pnas.1816298116. Epub 2019 Jan 18.


Agreement between blood draw techniques for assessing platelet activation by flow cytometry.

Welch EL, Crooks MG, Hart SP.

Platelets. 2019;30(4):530-534. doi: 10.1080/09537104.2018.1535705. Epub 2018 Oct 26.


Textural analysis demonstrates heterogeneous [18F]-fluorodeoxyglucose uptake in radiologically normal lung in patients with idiopathic pulmonary fibrosis.

Aliyu SA, Avery G, Cawthorne C, Archibald SJ, Kadir T, Willaime JMY, Morice AH, Hart SP, Crooks MG.

Eur Respir J. 2018 Nov 1;52(5). pii: 1801138. doi: 10.1183/13993003.01138-2018. Print 2018 Nov. No abstract available.


Effect of Ovar-DRA and Ovar-DRB1 genotype in small ruminants with haemonchosis.

Estrada-Reyes ZM, Tsukahara Y, Goetsch AL, Gipson TA, Sahlu T, Puchala R, Wang Z, Hart SP, Mateescu RG.

Parasite Immunol. 2018 Jun;40(6):e12534. doi: 10.1111/pim.12534.


Species' Distributions as a Coexistence Problem: A Response to Godsoe et al.

Alexander JM, Diez JM, Usinowicz J, Hart SP.

Trends Ecol Evol. 2018 Mar;33(3):144-145. doi: 10.1016/j.tree.2018.01.001. Epub 2018 Jan 31. No abstract available.


Inhaled beclomethasone/formoterol in idiopathic pulmonary fibrosis: a randomised controlled exploratory study.

Wright CE, Fraser SD, Brindle K, Morice AH, Hart SP, Crooks MG.

ERJ Open Res. 2017 Dec 14;3(4). pii: 00100-2017. doi: 10.1183/23120541.00100-2017. eCollection 2017 Oct.


Increased Propensity for Pneumonia with Fluticasone in Chronic Obstructive Pulmonary Disease.

Morice AH, Hart SP.

Am J Respir Crit Care Med. 2018 May 1;197(9):1229-1230. doi: 10.1164/rccm.201710-2092LE. No abstract available.


Psychometric validation of the needs assessment tool: progressive disease in interstitial lung disease.

Johnson MJ, Jamali A, Ross J, Fairhurst C, Boland J, Reigada C, Hart SP, Grande G, Currow DC, Wells AU, Bajwah S, Papadopoulos T, Bland JM, Yorke J.

Thorax. 2018 Sep;73(9):880-883. doi: 10.1136/thoraxjnl-2017-210911. Epub 2017 Nov 17.


Early clinical experiences with nintedanib in three UK tertiary interstitial lung disease centres.

Toellner H, Hughes G, Beswick W, Crooks MG, Donaldson C, Forrest I, Hart SP, Leonard C, Major M, Simpson AJ, Chaudhuri N.

Clin Transl Med. 2017 Nov 3;6(1):41. doi: 10.1186/s40169-017-0172-3.


Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.

Allen RJ, Porte J, Braybrooke R, Flores C, Fingerlin TE, Oldham JM, Guillen-Guio B, Ma SF, Okamoto T, John AE, Obeidat M, Yang IV, Henry A, Hubbard RB, Navaratnam V, Saini G, Thompson N, Booth HL, Hart SP, Hill MR, Hirani N, Maher TM, McAnulty RJ, Millar AB, Molyneaux PL, Parfrey H, Rassl DM, Whyte MKB, Fahy WA, Marshall RP, Oballa E, Bossé Y, Nickle DC, Sin DD, Timens W, Shrine N, Sayers I, Hall IP, Noth I, Schwartz DA, Tobin MD, Wain LV, Jenkins RG.

Lancet Respir Med. 2017 Nov;5(11):869-880. doi: 10.1016/S2213-2600(17)30387-9. Epub 2017 Oct 20.


The spatial scales of species coexistence.

Hart SP, Usinowicz J, Levine JM.

Nat Ecol Evol. 2017 Aug;1(8):1066-1073. doi: 10.1038/s41559-017-0230-7. Epub 2017 Jul 21. Review. Erratum in: Nat Ecol Evol. 2017 Sep;1(9):1411.


Publisher correction: The spatial scales of species coexistence.

Hart SP, Usinowicz J, Levine JM.

Nat Ecol Evol. 2017 Sep;1(9):1411. doi: 10.1038/s41559-017-0289-1.


Lipid Laden Macrophages in Respiratory Disease.

Sadofsky LR, Hayman YA, Hart SP, Morice AH.

J Neurogastroenterol Motil. 2017 Jul 30;23(3):477-478. doi: 10.5056/jnm17036. No abstract available.


British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders.

Hurst JR, Verma N, Lowe D, Baxendale HE, Jolles S, Kelleher P, Longhurst HJ, Patel SY, Renzoni EA, Sander CR, Avery GR, Babar JL, Buckland MS, Burns S, Egner W, Gompels MM, Gordins P, Haddock JA, Hart SP, Hayman GR, Herriot R, Hoyles RK, Huissoon AP, Jacob J, Nicholson AG, Rassl DM, Sargur RB, Savic S, Seneviratne SL, Sheaff M, Vaitla PM, Walters GI, Whitehouse JL, Wright PA, Condliffe AM.

J Allergy Clin Immunol Pract. 2017 Jul - Aug;5(4):938-945. doi: 10.1016/j.jaip.2017.01.021. Epub 2017 Mar 25. Review.


The effects of exogenous lipid on THP-1 cells: an in vitro model of airway aspiration?

Hayman YA, Sadofsky LR, Williamson JD, Hart SP, Morice AH.

ERJ Open Res. 2017 Mar 20;3(1). pii: 00026-2016. doi: 10.1183/23120541.00026-2016. eCollection 2017 Jan.


Reduced expression of monocyte CD200R is associated with enhanced proinflammatory cytokine production in sarcoidosis.

Fraser SD, Sadofsky LR, Kaye PM, Hart SP.

Sci Rep. 2016 Dec 8;6:38689. doi: 10.1038/srep38689.


Bleomycin increases neutrophil adhesion to human vascular endothelial cells independently of upregulation of ICAM-1 and E-selectin.

Williamson JD, Sadofsky LR, Crooks MG, Greenman J, Hart SP.

Exp Lung Res. 2016 Oct - Dec;42(8-10):397-407. doi: 10.1080/01902148.2016.1243742. Epub 2016 Oct 31.


When Climate Reshuffles Competitors: A Call for Experimental Macroecology.

Alexander JM, Diez JM, Hart SP, Levine JM.

Trends Ecol Evol. 2016 Nov;31(11):831-841. doi: 10.1016/j.tree.2016.08.003. Epub 2016 Sep 15. Review.


How variation between individuals affects species coexistence.

Hart SP, Schreiber SJ, Levine JM.

Ecol Lett. 2016 Aug;19(8):825-38. doi: 10.1111/ele.12618. Epub 2016 Jun 2.


Patient considerations and drug selection in the treatment of idiopathic pulmonary fibrosis.

Trawinska MA, Rupesinghe RD, Hart SP.

Ther Clin Risk Manag. 2016 Apr 8;12:563-74. doi: 10.2147/TCRM.S81144. eCollection 2016. Review.


The Adaptation, Face, and Content Validation of a Needs Assessment Tool: Progressive Disease for People with Interstitial Lung Disease.

Boland JW, Reigada C, Yorke J, Hart SP, Bajwah S, Ross J, Wells A, Papadopoulos A, Currow DC, Grande G, Macleod U, Johnson MJ.

J Palliat Med. 2016 May;19(5):549-55. doi: 10.1089/jpm.2015.0355. Epub 2016 Feb 3.


Idiopathic Pulmonary Fibrosis and Prothrombotic State.

Fahim A, Crooks MG, Morice AH, Hart SP.

Am J Respir Crit Care Med. 2016 Feb 1;193(3):341-2. doi: 10.1164/rccm.201509-1835LE. No abstract available.


Coagulation and anticoagulation in idiopathic pulmonary fibrosis.

Crooks MG, Hart SP.

Eur Respir Rev. 2015 Sep;24(137):392-9. doi: 10.1183/16000617.00008414. Review.


Magnetoencephalography to investigate central perception of exercise-induced breathlessness in people with chronic lung disease: a feasibility pilot.

Johnson MJ, Simpson MI, Currow DC, Millman RE, Hart SP, Green G.

BMJ Open. 2015 Jun 10;5(6):e007535. doi: 10.1136/bmjopen-2014-007535.


Individualized iterative phenotyping for genome-wide analysis of loss-of-function mutations.

Johnston JJ, Lewis KL, Ng D, Singh LN, Wynter J, Brewer C, Brooks BP, Brownell I, Candotti F, Gonsalves SG, Hart SP, Kong HH, Rother KI, Sokolic R, Solomon BD, Zein WM, Cooper DN, Stenson PD, Mullikin JC, Biesecker LG.

Am J Hum Genet. 2015 Jun 4;96(6):913-25. doi: 10.1016/j.ajhg.2015.04.013.


Radiotherapy for extensive stage small-cell lung cancer.

Hart SP, Morice AH.

Lancet. 2015 Apr 4;385(9975):1292. doi: 10.1016/S0140-6736(15)60678-X. No abstract available.


Biomarkers in idiopathic pulmonary fibrosis: picking the winners for trials.

Crooks MG, Hart SP.

Lancet Respir Med. 2015 Jun;3(6):421-2. doi: 10.1016/S2213-2600(15)00084-3. Epub 2015 Mar 12. No abstract available.


Tissue fibrocytes are a subpopulation of macrophages.

Hart SP.

Am J Respir Cell Mol Biol. 2015 Jan;52(1):138. doi: 10.1165/rcmb.2014-0151LE. No abstract available.


The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis.

Williamson JD, Sadofsky LR, Hart SP.

Exp Lung Res. 2015 Mar;41(2):57-73. doi: 10.3109/01902148.2014.979516. Epub 2014 Dec 16. Review.


A new era of drug therapy for idiopathic pulmonary fibrosis.

Crooks MG, Hart SP.

Lancet Respir Med. 2014 Dec;2(12):964-6. doi: 10.1016/S2213-2600(14)70257-7. Epub 2014 Nov 19. No abstract available.


Increased platelet reactivity in idiopathic pulmonary fibrosis is mediated by a plasma factor.

Crooks MG, Fahim A, Naseem KM, Morice AH, Hart SP.

PLoS One. 2014 Oct 22;9(10):e111347. doi: 10.1371/journal.pone.0111347. eCollection 2014.


Autonomic dysregulation: a mechanism of asthma death.

Morjaria JB, Rowland T, Tailor P, Hyder S, Wright CE, Hart SP, Morice AH.

Eur Respir J. 2014 Nov;44(5):1357-60. doi: 10.1183/09031936.00076414. Epub 2014 Aug 19. No abstract available.


Understanding CT patterns in idiopathic pulmonary fibrosis.

Hart SP.

Lancet Respir Med. 2014 Apr;2(4):249-50. doi: 10.1016/S2213-2600(14)70030-X. Epub 2014 Feb 18. No abstract available.


Environmental stress, facilitation, competition, and coexistence.

Hart SP, Marshall DJ.

Ecology. 2013 Dec;94(12):2719-31.


Increased platelet binding to circulating monocytes in idiopathic pulmonary fibrosis.

Fahim A, Crooks MG, Morice AH, Hart SP.

Lung. 2014 Apr;192(2):277-84. doi: 10.1007/s00408-013-9546-5. Epub 2014 Jan 7.


Emphysema and bronchiectasis secondary to alpha-1 antitrypsin deficiency.

Fahim A, Wilmot R, Hart SP.

J Coll Physicians Surg Pak. 2013 Mar;23(3):224-5. doi: 03.2013/JCPSP.224225.


Revisiting competition in a classic model system using formal links between theory and data.

Hart SP, Burgin JR, Marshall DJ.

Ecology. 2012 Sep;93(9):2015-22.


Pins and needles and unilateral foot drop: a presentation of sarcoidosis.

Fahim A, Kastelik JA, Morjaria JB, Hart SP.

BMJ Case Rep. 2012 Oct 19;2012. pii: bcr2012007395. doi: 10.1136/bcr-2012-007395.


No evidence on screening for cancer.

Hart SP.

BMJ. 2012 Jul 31;345:e5079; author reply e5098. doi: 10.1136/bmj.e5079. No abstract available.


Serum carcinoembryonic antigen correlates with severity of idiopathic pulmonary fibrosis.

Fahim A, Crooks MG, Wilmot R, Campbell AP, Morice AH, Hart SP.

Respirology. 2012 Nov;17(8):1247-52. doi: 10.1111/j.1440-1843.2012.02231.x.


Supplemental Content

Support Center